![Teva, AstraZeneca settle patent dispute involving diabetes drug Byetta - Philadelphia Business Journal Teva, AstraZeneca settle patent dispute involving diabetes drug Byetta - Philadelphia Business Journal](http://media.bizj.us/view/img/6047051/img0195*1200xx2448-2448-408-0.jpg)
Teva, AstraZeneca settle patent dispute involving diabetes drug Byetta - Philadelphia Business Journal
IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF MASSACHUSETTS TEVA PHARMACEUTICALS INTERNATIONAL GMBH, Plaintiff, v. EL
![Calcitonin gene-related peptide-targeting drugs for migraine: how pharmacology might inform treatment decisions - The Lancet Neurology Calcitonin gene-related peptide-targeting drugs for migraine: how pharmacology might inform treatment decisions - The Lancet Neurology](https://www.thelancet.com/cms/attachment/717c5ac7-14ad-4d09-bc73-1514ace68875/gr1_lrg.jpg)
Calcitonin gene-related peptide-targeting drugs for migraine: how pharmacology might inform treatment decisions - The Lancet Neurology
![Migraine therapeutics differentially modulate the CGRP pathway - Minoti Bhakta, Trang Vuong, Tetsuya Taura, David S Wilson, Jennifer R Stratton, Kimberly D Mackenzie, 2021 Migraine therapeutics differentially modulate the CGRP pathway - Minoti Bhakta, Trang Vuong, Tetsuya Taura, David S Wilson, Jennifer R Stratton, Kimberly D Mackenzie, 2021](https://journals.sagepub.com/cms/10.1177/0333102420983282/asset/images/large/10.1177_0333102420983282-fig5.jpeg)
Migraine therapeutics differentially modulate the CGRP pathway - Minoti Bhakta, Trang Vuong, Tetsuya Taura, David S Wilson, Jennifer R Stratton, Kimberly D Mackenzie, 2021
![Mixed pathologies in pancreatic β cells from subjects with neurodegenerative diseases and their interaction with prion protein | Acta Neuropathologica Communications | Full Text Mixed pathologies in pancreatic β cells from subjects with neurodegenerative diseases and their interaction with prion protein | Acta Neuropathologica Communications | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs40478-021-01171-0/MediaObjects/40478_2021_1171_Fig1_HTML.png)
Mixed pathologies in pancreatic β cells from subjects with neurodegenerative diseases and their interaction with prion protein | Acta Neuropathologica Communications | Full Text
![Venlafaxine hydrochloride (Wy 45030 hydrochloride) | Serotonin/Norepinephrine Reuptake Inhibitor | MedChemExpress Venlafaxine hydrochloride (Wy 45030 hydrochloride) | Serotonin/Norepinephrine Reuptake Inhibitor | MedChemExpress](https://file.medchemexpress.com/product_pic/hy-b0196a.gif)
Venlafaxine hydrochloride (Wy 45030 hydrochloride) | Serotonin/Norepinephrine Reuptake Inhibitor | MedChemExpress
![Provoked versus spontaneous migraine attacks: pathophysiological similarities and differences | The Journal of Headache and Pain | Full Text Provoked versus spontaneous migraine attacks: pathophysiological similarities and differences | The Journal of Headache and Pain | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs10194-022-01464-2/MediaObjects/10194_2022_1464_Fig1_HTML.png)
Provoked versus spontaneous migraine attacks: pathophysiological similarities and differences | The Journal of Headache and Pain | Full Text
![Mixed pathologies in pancreatic β cells from subjects with neurodegenerative diseases and their interaction with prion protein | Acta Neuropathologica Communications | Full Text Mixed pathologies in pancreatic β cells from subjects with neurodegenerative diseases and their interaction with prion protein | Acta Neuropathologica Communications | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs40478-021-01171-0/MediaObjects/40478_2021_1171_Fig2_HTML.png)
Mixed pathologies in pancreatic β cells from subjects with neurodegenerative diseases and their interaction with prion protein | Acta Neuropathologica Communications | Full Text
![Hypervigilance, Allostatic Load, and Migraine Prevention: Antibodies to CGRP or Receptor | Neurology and Therapy Hypervigilance, Allostatic Load, and Migraine Prevention: Antibodies to CGRP or Receptor | Neurology and Therapy](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs40120-021-00250-7/MediaObjects/40120_2021_250_Fig4_HTML.png)
Hypervigilance, Allostatic Load, and Migraine Prevention: Antibodies to CGRP or Receptor | Neurology and Therapy
![Mode and site of action of therapies targeting CGRP signaling | The Journal of Headache and Pain | Full Text Mode and site of action of therapies targeting CGRP signaling | The Journal of Headache and Pain | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs10194-023-01644-8/MediaObjects/10194_2023_1644_Fig2_HTML.png)